Open AccessIs aripiprazole a key to unlock anorexia nervosa?: A case series
Author(s) -
Tahıllıoğlu Akın,
Özcan Tuğçe,
Yüksel Gamze,
Majroh Noorjahan,
Köse Sezen,
Özbaran Burcu
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3271
Subject(s) - aripiprazole , anorexia nervosa , medicine , depression (economics) , body mass index , psychiatry , eating disorders , schizophrenia (object oriented programming) , economics , macroeconomics
Aripiprazole contributes an increase in body mass index and attenuation in anorexia nervosa (AN) symptoms, leading clinical improvements with lower side‐effect profile; but it is not enough to cure comorbid depressive symptoms in AN.